TQC3721

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TQC3721, covering 2025-04-17 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder [Phase 2]